Tristar Wellness Solutions Inc. (TWSI) 0.1303 $TWSI
HemCon Medical Technologies, Inc. Awarded Hemostasis and Compression Products Agreement With Premier, Inc.
PR Newswire - Mon Nov 03, 7:34AM CST
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the company has been awarded a group purchasing agreement for Hemostasis and Compression Products with Premier, Inc. effective November 1, 2014. The new agreement (PP-CA-248) allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the entire line of HemCon hemostatic products, including products such as the HemCon Patch® PRO, ideal for bleeding control following heart catheterizations, ChitoGauze® PRO for traumatic injuries and GuardaCare®XR Surgical, a must have tool for controlling bleeding and maintaining surgical field visibility in the operating room.
PINC: 33.05 (+0.70)
Ludlow Research Issues Opinion on TriStar Wellness Solutions Based on Pending Q3 Earnings, Valuation
PR Newswire - Mon Oct 20, 7:22AM CDT
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced that Ludlow Research has issued a research opinion of the Company based on strong Q3 revenue guidance, and current valuation.
HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues
PR Newswire - Tue Sep 16, 7:35AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the revenue performance on their chitosan technology platform has grown by 39 percent, and microdispersed oxidized cellulose raw material is up 22 percent year-to-date though August 2014. Overall, TWSI expects third quarter revenues to surpass the prior year in excess of 50 percent and be in line with overall business expectations for 2014.
HemCon Medical Technologies, Inc. Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development
PR Newswire - Wed Sep 03, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that they will be exclusively focusing company resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems and upgrading all internal information systems immediately.
HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze(R) Published in Leading European Trauma Journal
PRWeb - Fri Jun 13, 7:06AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze(R) on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands.
HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
PR Newswire - Thu Jun 12, 7:00AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze® on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands.
TriStar Wellness CEO John Linderman to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Tue Mar 25, 9:34AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, today announced that CEO John Linderman will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
HemCon Medical Technologies Revenue Growth Surges in Japan
PR Newswire - Mon Mar 24, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today significant sales growth and momentum for the HemCon hemostatic product line in Japan. Sales for the first quarter of 2014 exceed overall sales for the previous year, and are trending to bring significant growth for the remainder of the year. This growth is fueled by new focus on sales and marketing efforts of HemCon's exclusive partner in Japan, Zeria Pharmaceuticals Ltd. Co. (Zeria), who has worked with the HemCon product line since 2010, ensuring the current and newly developed products become the standard of care for hemostasis in the country. Japan has the third largest global woundcare market, estimated to growth to $2.3B by 2016[1].
HemCon Medical Technologies Launches Online Sales Initiative Offering Innovative Oral Woundcare Technology
PR Newswire - Wed Mar 19, 7:26AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that it is launching its ecommerce online store www.hemcondental.com. The store will be specific to HemCon's chitosan oral surgery product line featuring the HemCon Dental Dressing. This dressing is designed to be used by oral surgeons, periodontist and general practitioners following tooth extractions and other oral procedures.
HemCon Medical Technologies Builds Global Momentum in Dialysis Market
PR Newswire - Mon Mar 17, 7:00AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announced that HemCon Medical Technologies, a wholly owned subsidiary of TWSI, has launched a global initiative to target the hemodialysis market with a new product from the chitosan line of hemostatic and antibacterial barrier devices family.
HemCon Medical Technologies Aims to Capitalize on European Growth
PR Newswire - Mon Mar 10, 7:43AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announced today that its wholly owned subsidiary HemCon Medical Technologies, Inc. has instituted a growth plan for European expansion.
HemCon Medical Technologies Appoints New Chief Financial Officer
PR Newswire - Wed Mar 05, 7:30AM CST
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announces the recent appointment of Stuart Sands as the Chief Financial Officer of its wholly owned subsidiary, HemCon Medical Technologies, Inc.
Beaute de Maman® Brand Raises the Bar on Natural Ingredients
PR Newswire - Tue Mar 04, 6:30AM CST
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a diversified health and wellness company, is pleased to announce that it is launching a major product enhancement initiative to further elevate the percent of naturally derived ingredients in its Beauté de Maman® brand of beauty and wellness products for pregnant and nursing women, from current industry norms to 95%+ -- a new standard. The product enhancement effort, which has already been completed for 20% of the line, will further differentiate the Beauté de Maman® brand in the marketplace.
TriStar Wellness Solutions® Further Expands Patent Portfolio in Asia
PR Newswire - Thu Feb 27, 6:00AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, adds another patent to its vast domestic and international intellectual property portfolio. This most recent patent number ZL200680047919.X was granted to HemCon Medical Technologies Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges in China, supporting the company's emerging status in this large market.
TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
TriStar Wellness Solutions Initiates National Sales Force and Marketing Communications for HemCon Medical Technologies Subsidiary
Business Wire - Mon Sep 16, 7:00AM CDT
TriStar Wellness Solutions, Inc. (OTCQB:TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has now hired several key positions for nationwide sales coverage and marketing communications for its wholly owned subsidiary HemCon Medical Technologies Inc.
TriStar Wellness Solutions Appoints Bill Shields as SVP of Sales and Business Development for HemCon Medical Technologies Subsidiary
Business Wire - Wed Jul 24, 7:45AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has appointed Bill Shields as Sr. Vice President of Sales and Business Development for its wholly owned subsidiary HemCon Medical Technologies Inc.
OSUR: 8.77 (-0.19)
TriStar Wellness Solutions Appoints Clemence Edelman as Marketing Director for Beaute de Maman(TM) Product Line
Business Wire - Tue Jul 02, 8:13AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has appointed Clemence Edelman as Marketing Director for its women's health products. In this role, Ms. Edelman will oversee Beaute de Maman's sales, marketing and product development efforts for the women's health portfolio.
TriStar Wellness Solutions' Beaute de Maman(TM) Product Line Discussed on WCBS Newsradio 880
Business Wire - Mon Jun 24, 11:02AM CDT
Michele Brown, M.D., founder of Beaute de Maman(TM), TriStar Wellness Solutions, Inc.'s (OTCQB: TWSI) brand of women's health products, was interviewed by Pat Farnack on the Health and Well Being Report on WCBS Newsradio 880 in New York City on June 14.
TriStar Wellness Solutions Obtains U.S. Patent for Manufacturing Process for m.doc(TM) Bleeding Control Technology
Business Wire - Thu Jun 13, 6:30AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has been awarded U.S. Patent No. 8,445,671 for the manufacturing process for m.doc(TM) bleeding control technology. The patent was granted to HemCon Medical Technologies Inc., a wholly owned subsidiary of TriStar Wellness Solutions, on May 21. m.doc(TM) technology currently serves as the basis of an OTC healthcare product line that has been marketed in the European Union and selectively in the U.S. by HemCon; the new patent gives TriStar patent protection for m.doc(TM) until August 30, 2028, and the company plans a comprehensive launch of m.doc(TM) products in the U.S. OTC market.
HemCon Medical Technologies, Inc. Awarded Hemostasis and Compression Products Agreement With Premier, Inc.
PR Newswire - Mon Nov 03, 7:34AM CST
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the company has been awarded a group purchasing agreement for Hemostasis and Compression Products with Premier, Inc. effective November 1, 2014. The new agreement (PP-CA-248) allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the entire line of HemCon hemostatic products, including products such as the HemCon Patch® PRO, ideal for bleeding control following heart catheterizations, ChitoGauze® PRO for traumatic injuries and GuardaCare®XR Surgical, a must have tool for controlling bleeding and maintaining surgical field visibility in the operating room. PINC: 33.05 (+0.70)
Ludlow Research Issues Opinion on TriStar Wellness Solutions Based on Pending Q3 Earnings, Valuation
PR Newswire - Mon Oct 20, 7:22AM CDT
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced that Ludlow Research has issued a research opinion of the Company based on strong Q3 revenue guidance, and current valuation.
HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues
PR Newswire - Tue Sep 16, 7:35AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the revenue performance on their chitosan technology platform has grown by 39 percent, and microdispersed oxidized cellulose raw material is up 22 percent year-to-date though August 2014. Overall, TWSI expects third quarter revenues to surpass the prior year in excess of 50 percent and be in line with overall business expectations for 2014. HemCon Medical Technologies, Inc. Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development
PR Newswire - Wed Sep 03, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that they will be exclusively focusing company resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems and upgrading all internal information systems immediately. HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze(R) Published in Leading European Trauma Journal
PRWeb - Fri Jun 13, 7:06AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze(R) on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands. HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
PR Newswire - Thu Jun 12, 7:00AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze® on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands. TriStar Wellness CEO John Linderman to Be Interviewed Live Today on Clear Channel Business Talk Radio
Marketwire - Tue Mar 25, 9:34AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, today announced that CEO John Linderman will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
HemCon Medical Technologies Revenue Growth Surges in Japan
PR Newswire - Mon Mar 24, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today significant sales growth and momentum for the HemCon hemostatic product line in Japan. Sales for the first quarter of 2014 exceed overall sales for the previous year, and are trending to bring significant growth for the remainder of the year. This growth is fueled by new focus on sales and marketing efforts of HemCon's exclusive partner in Japan, Zeria Pharmaceuticals Ltd. Co. (Zeria), who has worked with the HemCon product line since 2010, ensuring the current and newly developed products become the standard of care for hemostasis in the country. Japan has the third largest global woundcare market, estimated to growth to $2.3B by 2016[1]. HemCon Medical Technologies Launches Online Sales Initiative Offering Innovative Oral Woundcare Technology
PR Newswire - Wed Mar 19, 7:26AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that it is launching its ecommerce online store www.hemcondental.com. The store will be specific to HemCon's chitosan oral surgery product line featuring the HemCon Dental Dressing. This dressing is designed to be used by oral surgeons, periodontist and general practitioners following tooth extractions and other oral procedures. HemCon Medical Technologies Builds Global Momentum in Dialysis Market
PR Newswire - Mon Mar 17, 7:00AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announced that HemCon Medical Technologies, a wholly owned subsidiary of TWSI, has launched a global initiative to target the hemodialysis market with a new product from the chitosan line of hemostatic and antibacterial barrier devices family.
HemCon Medical Technologies Aims to Capitalize on European Growth
PR Newswire - Mon Mar 10, 7:43AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announced today that its wholly owned subsidiary HemCon Medical Technologies, Inc. has instituted a growth plan for European expansion.
HemCon Medical Technologies Appoints New Chief Financial Officer
PR Newswire - Wed Mar 05, 7:30AM CST
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announces the recent appointment of Stuart Sands as the Chief Financial Officer of its wholly owned subsidiary, HemCon Medical Technologies, Inc.
Beaute de Maman® Brand Raises the Bar on Natural Ingredients
PR Newswire - Tue Mar 04, 6:30AM CST
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a diversified health and wellness company, is pleased to announce that it is launching a major product enhancement initiative to further elevate the percent of naturally derived ingredients in its Beauté de Maman® brand of beauty and wellness products for pregnant and nursing women, from current industry norms to 95%+ -- a new standard. The product enhancement effort, which has already been completed for 20% of the line, will further differentiate the Beauté de Maman® brand in the marketplace.
TriStar Wellness Solutions® Further Expands Patent Portfolio in Asia
PR Newswire - Thu Feb 27, 6:00AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, adds another patent to its vast domestic and international intellectual property portfolio. This most recent patent number ZL200680047919.X was granted to HemCon Medical Technologies Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges in China, supporting the company's emerging status in this large market.
TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
TriStar Wellness Solutions Initiates National Sales Force and Marketing Communications for HemCon Medical Technologies Subsidiary
Business Wire - Mon Sep 16, 7:00AM CDT
TriStar Wellness Solutions, Inc. (OTCQB:TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has now hired several key positions for nationwide sales coverage and marketing communications for its wholly owned subsidiary HemCon Medical Technologies Inc.
TriStar Wellness Solutions Appoints Bill Shields as SVP of Sales and Business Development for HemCon Medical Technologies Subsidiary
Business Wire - Wed Jul 24, 7:45AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has appointed Bill Shields as Sr. Vice President of Sales and Business Development for its wholly owned subsidiary HemCon Medical Technologies Inc.
OSUR: 8.77 (-0.19)
TriStar Wellness Solutions Appoints Clemence Edelman as Marketing Director for Beaute de Maman(TM) Product Line
Business Wire - Tue Jul 02, 8:13AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has appointed Clemence Edelman as Marketing Director for its women's health products. In this role, Ms. Edelman will oversee Beaute de Maman's sales, marketing and product development efforts for the women's health portfolio.
TriStar Wellness Solutions' Beaute de Maman(TM) Product Line Discussed on WCBS Newsradio 880
Business Wire - Mon Jun 24, 11:02AM CDT
Michele Brown, M.D., founder of Beaute de Maman(TM), TriStar Wellness Solutions, Inc.'s (OTCQB: TWSI) brand of women's health products, was interviewed by Pat Farnack on the Health and Well Being Report on WCBS Newsradio 880 in New York City on June 14.
TriStar Wellness Solutions Obtains U.S. Patent for Manufacturing Process for m.doc(TM) Bleeding Control Technology
Business Wire - Thu Jun 13, 6:30AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has been awarded U.S. Patent No. 8,445,671 for the manufacturing process for m.doc(TM) bleeding control technology. The patent was granted to HemCon Medical Technologies Inc., a wholly owned subsidiary of TriStar Wellness Solutions, on May 21. m.doc(TM) technology currently serves as the basis of an OTC healthcare product line that has been marketed in the European Union and selectively in the U.S. by HemCon; the new patent gives TriStar patent protection for m.doc(TM) until August 30, 2028, and the company plans a comprehensive launch of m.doc(TM) products in the U.S. OTC market.
